Related Experiment Video
Updated: Mar 27, 2026
Whole Vitreous Humor Dissection for Vitreodynamic Analysis
Published on: May 24, 2015
EFFICACY AND SAFETY OF TREATMENT OPTIONS FOR VITREOMACULAR TRACTION: A Case Series and Meta-Analysis
Gina Yu1, James Duguay, Kyle V Marra
1*Division of Ophthalmology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; †Division of Ophthalmology, University of California, San Diego School of Medicine, La Jolla, California; ‡Division of Ophthalmology, Lille University School of Medicine, Lille, France; and §Boston University School of Medicine, Boston, Massachusetts.
Pneumatic vitreolysis (PV) effectively resolves vitreomacular traction (VMT) in most patients. This study suggests PV may be superior to nonsurgical options for VMT release with a comparable safety profile.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Surgical Interventions
Background:
- Vitreomacular traction (VMT) is a condition where the vitreous gel adheres abnormally to the macula.
- Effective treatment options for VMT are crucial for preserving visual function.
Purpose of the Study:
- To evaluate and compare the efficacy of different treatment modalities for vitreomacular traction (VMT).
Main Methods:
- A retrospective case series and a comprehensive literature search were performed.
- A random-effects meta-analysis was conducted to assess VMT resolution rates across various treatments.
- Patients were grouped by treatment: control, intravitreal ocriplasmin (IVO), pneumatic vitreolysis (PV), and pars plana vitrectomy (PPV).
Main Results:
- Pneumatic vitreolysis (PV) demonstrated a high VMT resolution rate of 0.84 (95% CI: 0.76-0.92).
- Intravitreal ocriplasmin (IVO) showed a resolution rate of 0.26 (95% CI: 0.23-0.29), while the control group had a rate of 0.09 (95% CI: 0.06-0.13).
- Pars plana vitrectomy (PPV) achieved 100% VMT release, with PV showing comparable efficacy to PPV in the case series.
Conclusions:
- Pneumatic vitreolysis (PV) is a highly effective treatment for vitreomacular traction (VMT).
- PV may offer comparable or superior efficacy to nonsurgical treatments for VMT release at 28 days.
- The risk profile for PV appears similar to other treatment options, with no increased incidence of retinal tears or detachment observed.
